Thurston, Springer, Miller, Herd & Titak, Inc. Amgen Inc Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $730 Million
- Q2 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 11,193 shares of AMGN stock, worth $3.19 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
11,193
Previous 9,725
15.1%
Holding current value
$3.19 Million
Previous $3.03 Million
3.17%
% of portfolio
0.43%
Previous 0.54%
Shares
6 transactions
Others Institutions Holding AMGN
# of Institutions
3,273Shares Held
434MCall Options Held
7.34MPut Options Held
7.36M-
Vanguard Group Inc Valley Forge, PA53.7MShares$15.3 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.1 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.32 Billion0.38% of portfolio
-
Capital International Investors Los Angeles, CA18.9MShares$5.39 Billion0.95% of portfolio
-
Capital World Investors Los Angeles, CA16.9MShares$4.8 Billion0.71% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $152B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...